Translational Development Acquisition Corp. (TDAC) is a Shell Companies company in the Financial Services sector, currently trading at $10.60. It has a SharesGrow Score of 51/100, indicating a mixed investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of TDAC = $9.76 (-7.9% from the current price, the stock appears fairly valued).
Valuation: TDAC trades at a trailing Price-to-Earnings (P/E) of 28.7 (S&P 500 average ~25).
Net income is $6M, growing at +2852.6%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).
Balance sheet: total debt is $0 with negative equity of -$7M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.07 (tight liquidity). Debt-to-assets is 0%. Total assets: $182M.
Analyst outlook: 1 / 1 analysts rate TDAC as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 60/100 (Pass), Growth 100/100 (Pass), Past 25/100 (Fail), Health 0/100 (Fail), Moat 28/100 (Fail), Future 100/100 (Pass), Income ?/100 (Fail).
